ClinicalTrials.gg
Sign In

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

DexCom, Inc. clinical trials

The registry lists 35 studies whose lead sponsor is DexCom, Inc.. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 2, 2026.

Get an email when these change. Save the DexCom, Inc. studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
24
Status unknown
6
Active, not recruiting
4
Not yet recruiting
1

Phase

Phase 1
1
Phase 4
1

Where

United States
30
Canada
2
Saudi Arabia
1

Registry sponsor names on this page

Each name exactly as ClinicalTrials.gov lists it, and how it relates to DexCom, Inc..

  • DexCom, Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    35 studies

Focus areas

Conditions DexCom, Inc. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Diabetes Mellitus27

Studies

Recruiting first, then most recently updated. Showing 35 of 35.